Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? - Authors' reply.
Saved in:
| Title: | Anti-BCMA CAR T-cell for IgG4-related disease: is this necessary? - Authors' reply. |
|---|---|
| Authors: | Cai S; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Hu Z; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Chen Y; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Ye C; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China., Zhang J; Shenzhen Pregene Biopharma Company, Shenzhen, China., Sun W; Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Dong L; Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: tjhdongll@163.com. |
| Source: | The Lancet. Rheumatology [Lancet Rheumatol] 2026 Apr; Vol. 8 (4), pp. e247-e248. Date of Electronic Publication: 2026 Feb 18. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2665-9913 (Electronic) Linking ISSN: 26659913 NLM ISO Abbreviation: Lancet Rheumatol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
